These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17090932)

  • 1. Enhanced daunomycin accumulation in human intestinal Caco-2 cells from non-ionic food emulsifiers unrelated to the p-glycoprotein inhibitory mechanism.
    Takaishi N; Satsu H; Shimizu M
    Biosci Biotechnol Biochem; 2006 Nov; 70(11):2703-11. PubMed ID: 17090932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nonylphenol ethoxylates (NPEs) on barrier functions of epithelial cell membranes: opening of tight junctions and competitive inhibition of P-gp-mediated efflux.
    Doo MH; Li H; Jang HI; Song IS; Chung SJ; Shim CK
    Int J Pharm; 2005 Sep; 302(1-2):145-53. PubMed ID: 16111844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-glycoprotein-mediated transport of berberine across Caco-2 cell monolayers.
    Maeng HJ; Yoo HJ; Kim IW; Song IS; Chung SJ; Shim CK
    J Pharm Sci; 2002 Dec; 91(12):2614-21. PubMed ID: 12434406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro predictability of drug-drug interaction likelihood of P-glycoprotein-mediated efflux of dabigatran etexilate based on [I]2/IC50 threshold.
    Kishimoto W; Ishiguro N; Ludwig-Schwellinger E; Ebner T; Schaefer O
    Drug Metab Dispos; 2014 Feb; 42(2):257-63. PubMed ID: 24212378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of diosmin, a flavonoid glycoside in citrus fruits, on P-glycoprotein-mediated drug efflux in human intestinal Caco-2 cells.
    Yoo HH; Lee M; Chung HJ; Lee SK; Kim DH
    J Agric Food Chem; 2007 Sep; 55(18):7620-5. PubMed ID: 17676865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of P-glycoprotein in the efflux of raltegravir from human intestinal cells and CD4+ T-cells as an interaction target for anti-HIV agents.
    Hashiguchi Y; Hamada A; Shinohara T; Tsuchiya K; Jono H; Saito H
    Biochem Biophys Res Commun; 2013 Sep; 439(2):221-7. PubMed ID: 23981805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-glycoprotein is responsible for the poor intestinal absorption and low toxicity of oral aconitine: in vitro, in situ, in vivo and in silico studies.
    Yang C; Zhang T; Li Z; Xu L; Liu F; Ruan J; Liu K; Zhang Z
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):561-8. PubMed ID: 24120885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition mechanism of P-glycoprotein mediated efflux by mPEG-PLA and influence of PLA chain length on P-glycoprotein inhibition activity.
    Li W; Li X; Gao Y; Zhou Y; Ma S; Zhao Y; Li J; Liu Y; Wang X; Yin D
    Mol Pharm; 2014 Jan; 11(1):71-80. PubMed ID: 24256068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sucrose esters increase drug penetration, but do not inhibit p-glycoprotein in caco-2 intestinal epithelial cells.
    Kiss L; Hellinger É; Pilbat AM; Kittel Á; Török Z; Füredi A; Szakács G; Veszelka S; Sipos P; Ózsvári B; Puskás LG; Vastag M; Szabó-Révész P; Deli MA
    J Pharm Sci; 2014 Oct; 103(10):3107-19. PubMed ID: 25042090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Schisandra lignans on P-glycoprotein-mediated drug efflux in human intestinal Caco-2.
    Yoo HH; Lee M; Lee MW; Lim SY; Shin J; Kim DH
    Planta Med; 2007 May; 73(5):444-50. PubMed ID: 17566147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colonic cell line Caco-2.
    Collett A; Higgs NB; Sims E; Rowland M; Warhurst G
    J Pharmacol Exp Ther; 1999 Jan; 288(1):171-8. PubMed ID: 9862768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal permeability and P-glycoprotein-mediated efflux transport of ticagrelor in Caco-2 monolayer cells.
    Marsousi N; Doffey-Lazeyras F; Rudaz S; Desmeules JA; Daali Y
    Fundam Clin Pharmacol; 2016 Dec; 30(6):577-584. PubMed ID: 27416295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs: in vitro/in vivo case studies.
    Constantinides PP; Wasan KM
    J Pharm Sci; 2007 Feb; 96(2):235-48. PubMed ID: 17051593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
    Dahan A; Amidon GL
    Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement effect of P-gp inhibitors on the intestinal absorption and antiproliferative activity of bestatin.
    Huo X; Liu Q; Wang C; Meng Q; Sun H; Peng J; Ma X; Liu K
    Eur J Pharm Sci; 2013 Nov; 50(3-4):420-8. PubMed ID: 23981338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hr-IL2 treatment on intestinal P-glycoprotein expression and activity in Caco-2 cells.
    Belliard AM; Tardivel S; Farinotti R; Lacour B; Leroy C
    J Pharm Pharmacol; 2002 Aug; 54(8):1103-9. PubMed ID: 12195825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mibefradil is a P-glycoprotein substrate and a potent inhibitor of both P-glycoprotein and CYP3A in vitro.
    Wandel C; Kim RB; Guengerich FP; Wood AJ
    Drug Metab Dispos; 2000 Aug; 28(8):895-8. PubMed ID: 10901697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide mediates increased P-glycoprotein activity in interferon-{gamma}-stimulated human intestinal cells.
    Dixit SG; Zingarelli B; Buckley DJ; Buckley AR; Pauletti GM
    Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G533-40. PubMed ID: 15486347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ intestinal perfusion in knockout mice demonstrates inhibition of intestinal p-glycoprotein by ritonavir causing increased darunavir absorption.
    Holmstock N; Mols R; Annaert P; Augustijns P
    Drug Metab Dispos; 2010 Sep; 38(9):1407-10. PubMed ID: 20551242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-glycoprotein, multidrug resistance-associated proteins and human organic anion transporting polypeptide influence the intracellular accumulation of atazanavir.
    Janneh O; Anwar T; Jungbauer C; Kopp S; Khoo SH; Back DJ; Chiba P
    Antivir Ther; 2009; 14(7):965-74. PubMed ID: 19918100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.